2.46
price up icon0.00%   0.00
after-market Handel nachbörslich: 2.41 -0.05 -2.03%
loading
Schlusskurs vom Vortag:
$2.46
Offen:
$2.44
24-Stunden-Volumen:
3,134
Relative Volume:
0.01
Marktkapitalisierung:
$2.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$1.52M
KGV:
-0.3892
EPS:
-6.3213
Netto-Cashflow:
$-1.14M
1W Leistung:
-1.99%
1M Leistung:
-20.39%
6M Leistung:
-89.19%
1J Leistung:
-93.50%
1-Tages-Spanne:
Value
$2.4106
$2.47
1-Wochen-Bereich:
Value
$2.4101
$2.60
52-Wochen-Spanne:
Value
$0.6254
$74.94

Psyence Biomedical Ltd Stock (PBM) Company Profile

Name
Firmenname
Psyence Biomedical Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
12
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
PBM's Discussions on Twitter

Compare PBM vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PBM
Psyence Biomedical Ltd
2.46 2.82M 0 1.52M -1.14M -6.3213
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.34 121.46B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
745.77 78.93B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
700.45 43.87B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
313.41 42.07B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
284.05 31.65B 5.36B 287.73M 924.18M 2.5229

Psyence Biomedical Ltd Aktie (PBM) Neueste Nachrichten

pulisher
Mar 11, 2026

Institution Moves: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Insider Buying & Daily Stock Momentum Reports - baoquankhu1.vn

Mar 11, 2026
pulisher
Mar 11, 2026

Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone - The Manila Times

Mar 11, 2026
pulisher
Mar 11, 2026

Psyence Biomedical Ltd. Strengthens Pharmaceutical-Grade Manufacturing Capabilities Through Strategic Investment in PsyLabs - Quiver Quantitative

Mar 11, 2026
pulisher
Mar 11, 2026

Inside Psyence BioMed’s debt-free push into $8.75B psychedelic drugs - Stock Titan

Mar 11, 2026
pulisher
Mar 09, 2026

Aug Rallies: Is 1stdibsCom Inc stock a smart retirement pick2026 PreEarnings & AI Driven Stock Reports - baoquankhu1.vn

Mar 09, 2026
pulisher
Mar 09, 2026

Aug Highlights: Will Psyence Biomedical Ltd. Equity Warrant be affected by tariffs2026 Market Sentiment & Free Verified High Yield Trade Plans - baoquankhu1.vn

Mar 09, 2026
pulisher
Mar 07, 2026

Death Cross: Whats the beta of Psyence Biomedical Ltd stockPortfolio Growth Summary & High Win Rate Trade Tips - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 07, 2026

Can Psyence Biomedical Ltd. stock withstand economic slowdownJuly 2025 Intraday Action & Accurate Entry and Exit Point Alerts - Naître et grandir

Mar 07, 2026
pulisher
Mar 07, 2026

Market Outlook: Will Psyence Biomedical Ltd Equity Warrant benefit from government policyTrade Exit Summary & Long-Term Capital Growth Ideas - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 07, 2026

Aug PostEarnings: Will Psyence Biomedical Ltd outperform its industry peers2025 Trade Ideas & Precise Trade Entry Recommendations - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Gainers Report: Is Psyence Biomedical Ltd a top pick in the sector2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 04, 2026

How Psyence Biomedical Ltd. stock performs in interest rate cyclesWall Street Watch & High Yield Equity Trading Tips - mfd.ru

Mar 04, 2026
pulisher
Mar 03, 2026

Psyence Biomed announces export of GMP-manufactured natural psilocybin (NPX-5) to Australia for ongoing clinical trial phase IIb - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial - The Manila Times

Mar 03, 2026
pulisher
Mar 03, 2026

Natural psilocybin shipped to Australia for cancer palliative care trial - Stock Titan

Mar 03, 2026
pulisher
Mar 02, 2026

Psyence Biomedical Finalizes PsyLabs Share Swap, Settlement-Linked Loan and Board Changes - TipRanks

Mar 02, 2026
pulisher
Mar 02, 2026

Large share exchange boosts Psyence Labs’ stake in Psyence Biomedical (PBM) - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

VIX Spike: Will Psyence Biomedical Ltd Equity Warrant outperform tech stocks2025 Market Sentiment & Verified Entry Point Signals - baoquankhu1.vn

Mar 01, 2026
pulisher
Mar 01, 2026

Aug EndMonth: Can Psyence Biomedical Ltd Equity Warrant beat the S P 5002025 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn

Mar 01, 2026
pulisher
Feb 28, 2026

Will Psyence Biomedical Ltd. Equity Warrant benefit from government policyGap Down & Accurate Technical Buy Alerts - mfd.ru

Feb 28, 2026
pulisher
Feb 27, 2026

PBM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

PBM Earnings History & Surprises | EPS & Revenue Results | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill

Feb 27, 2026
pulisher
Feb 25, 2026

PBM PE Ratio & Valuation, Is PBM Overvalued - Intellectia AI

Feb 25, 2026
pulisher
Feb 25, 2026

Psyence Biomedical shares rise following equity investment agreement - MSN

Feb 25, 2026
pulisher
Feb 24, 2026

Movement Recap: Is Psyence Biomedical Ltd Equity Warrant undervalued by DCF analysisMarket Activity Report & Community Verified Watchlist Alerts - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 23, 2026

Psyence BioMed Announces Exercise Of Put Option By Psyence Labs; Stock Up - Nasdaq

Feb 23, 2026
pulisher
Feb 23, 2026

Psyence Biomedical stock gains on equity investment deal By Investing.com - Investing.com Canada

Feb 23, 2026
pulisher
Feb 21, 2026

Aug Rallies: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Trade Ideas & AI Forecast Swing Trade Picks - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 20, 2026

Is Psyence Biomedical Ltd.’s ROIC above industry averageJuly 2025 Setups & Community Verified Watchlist Alerts - mfd.ru

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence Biomedical Shares Soar 70% Following Partner’s Ibogaine Extraction Breakthrough - MSN

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence BioMed Exercises Put Option to Invest in PsyLabs - Intellectia AI

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence Biomedical Cedes 49.98% Stake to PsyLabs in US$5 Million Share Swap - TipRanks

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence Biomedical Ltd. Invests in Psyence Labs Ltd. to Enhance Strategic Relationship and Supply Chain Capabilities - Quiver Quantitative

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment - The Spec

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence Biomedical Shareholders Approve Board, Auditor and Share Consolidation Authority - The Globe and Mail

Feb 20, 2026
pulisher
Feb 20, 2026

PBM SEC FilingsPsyence Biomedical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 20, 2026
pulisher
Feb 20, 2026

Does Psyence Biomedical Ltd. stock have upside surprise potential2025 Buyback Activity & Reliable Entry Point Trade Alerts - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Weiner discloses 51,850-share, 5.07% stake in Psyence Biomedical (PBM) - Stock Titan

Feb 19, 2026
pulisher
Feb 18, 2026

Growth Review: Does Bitfarms Ltd align with a passive investing strategyTrade Performance Summary & Real-Time Stock Entry Alerts - baoquankhu1.vn

Feb 18, 2026
pulisher
Feb 18, 2026

Will Psyence Biomedical Ltd. outperform its industry peersMarket Sentiment Report & Precise Trade Entry Recommendations - mfd.ru

Feb 18, 2026
pulisher
Feb 17, 2026

Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders - Bitget

Feb 17, 2026
pulisher
Feb 17, 2026

Psyence Biomedical Ltd. Announces Shareholder Meeting Results, Directors Elected and Share Consolidation Authority Granted - Quiver Quantitative

Feb 17, 2026
pulisher
Feb 17, 2026

Psilocybin developer’s investors back plan to combine shares up to 250-for-1 - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

Sectors Review: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Weekly Loss Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn

Feb 16, 2026
pulisher
Feb 14, 2026

Why Psyence Biomedical Ltd. Equity Warrant stock could outperform in 2025Oil Prices & AI Forecast for Swing Trade Picks - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Psyence Biomedical Ratifies Put Option Deal With PsyLabs to Secure Psychedelic Supply - The Globe and Mail

Feb 14, 2026
pulisher
Feb 13, 2026

PsyLabs Secures Strategic Put Option Deal With Psyence BioMed to Scale Psychedelic API Manufacturing - TipRanks

Feb 13, 2026
pulisher
Feb 13, 2026

Psyence BioMed Enters Put Option Agreement with PsyLabs - Intellectia AI

Feb 13, 2026
pulisher
Feb 13, 2026

Psyence Biomedical Ltd. Enters Put Option Agreement with PsyLabs to Strengthen Strategic Partnership in Psychedelic Manufacturing - Quiver Quantitative

Feb 13, 2026
pulisher
Feb 13, 2026

Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway - The Spec

Feb 13, 2026
pulisher
Feb 12, 2026

Psyence Biomedical Settles Shareholder Dispute With KAOS Capital - TipRanks

Feb 12, 2026

Finanzdaten der Psyence Biomedical Ltd-Aktie (PBM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):